We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2776
Ardelyx
ARDX
$844M
| $1K | ﹤0.01% |
1,000
| – | – |
2018 Q4
11 quarters
|
|
2777
Artesian Resources
ARTNA
$342M
| $1K | ﹤0.01% |
28
| – | – |
2020 Q3
4 quarters
|
|
2778
AdvanSix
ASIX
$446M
| $1K | ﹤0.01% |
23
| – | – |
2016 Q4
19 quarters
|
|
2779
AST SpaceMobile
ASTS
$13.3B
| $1K | ﹤0.01% |
100
+46
| +85% | +$516 |
2021 Q2
1 quarter
|
|
2780
Atkore
ATKR
$3.21B
| $1K | ﹤0.01% |
14
| – | – |
2021 Q1
2 quarters
|
|
2781
American Vanguard Corp
AVD
$36.9M
| $1K | ﹤0.01% |
+51
| New | +$806 |
2021 Q3
0 quarters
|
|
2782
Anavex Life Sciences
AVXL
$137M
| $1K | ﹤0.01% |
79
| – | – |
2021 Q2
1 quarter
|
|
2783
DELISTED
Azul
AZUL
| $1K | ﹤0.01% |
47
+46
| +4,600% | +$1.01K |
2020 Q1
6 quarters
|
|
2784
Invesco Taxable Municipal Bond ETF
BAB
$858M
| $1K | ﹤0.01% |
16
+1
| +7% | +$34 |
2018 Q4
11 quarters
|
|
2785
GraniteShares Gold Shares
BAR
$1.36B
| $1K | ﹤0.01% |
37
| – | – |
2021 Q2
1 quarter
|
|
2786
Saul Centers
BFS
$720M
| $1K | ﹤0.01% |
+13
| New | +$586 |
2021 Q3
0 quarters
|
|
2787
BGC Group
BGC
$5.41B
| $1K | ﹤0.01% |
152
+1
| +0.7% | +$5 |
2019 Q2
9 quarters
|
|
2788
Bloomin' Brands
BLMN
$850M
| $1K | ﹤0.01% |
+36
| New | +$932 |
2021 Q3
0 quarters
|
|
2789
Bolt Biotherapeutics
BOLT
$8.17M
| $1K | ﹤0.01% |
4
+1
| +33% | +$283 |
2021 Q2
1 quarter
|
|
2790
Brady Corp
BRC
$3.94B
| $1K | ﹤0.01% |
+15
| New | +$790 |
2021 Q3
0 quarters
|
|
2791
Beazer Homes USA
BZH
$891M
| $1K | ﹤0.01% |
+62
| New | +$1.11K |
2021 Q3
0 quarters
|
|
2792
Camden National
CAC
$944M
| $1K | ﹤0.01% |
20
| – | – |
2021 Q1
2 quarters
|
|
2793
Credit Acceptance
CACC
$5.71B
| $1K | ﹤0.01% |
+2
| New | +$1.09K |
2021 Q3
0 quarters
|
|
2794
Caleres
CAL
$453M
| $1K | ﹤0.01% |
+30
| New | +$724 |
2021 Q3
0 quarters
|
|
2795
Calix
CALX
$2.34B
| $1K | ﹤0.01% |
27
+14
| +108% | +$646 |
2021 Q1
2 quarters
|
|
2796
DELISTED
Carisma Therapeutics
CARM
| $1K | ﹤0.01% |
38
-27
| -42% | -$1.3K |
2019 Q4
7 quarters
|
|
2797
DELISTED
Cross Country Healthcare
CCRN
| $1K | ﹤0.01% |
+31
| New | +$582 |
2021 Q3
0 quarters
|
|
2798
Cadiz
CDZI
$323M
| $1K | ﹤0.01% |
196
| – | – |
2020 Q1
6 quarters
|
|
2799
Century Aluminum
CENX
$3.39B
| $1K | ﹤0.01% |
+49
| New | +$616 |
2021 Q3
0 quarters
|
|
2800
CEVA Inc
CEVA
$824M
| $1K | ﹤0.01% |
13
-50
| -79% | -$2.27K |
2021 Q2
1 quarter
|
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.